Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Altasciences

Altasciences and Evidence Matters Announce Strategic Collaboration to Advance AI-Enhanced Text Engineering for Regulatory Writing in Life Sciences
From Altasciences
Via Business Wire
Altasciences Chosen by Steel Therapeutics to Support the Launch of Pivotal Toxicology Study for Fizurex™
From Altasciences
Via Business Wire
Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts
From Altasciences
Via Business Wire
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development
From Altasciences
Via Business Wire
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category
From Altasciences
Via Business Wire
CORRECTING and REPLACING Altasciences Supports Metsera in Their Early-Stage Clinical Trials for Obesity
From Altasciences
Via Business Wire
Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services
From Altasciences
Via Business Wire
Altasciences’ Chief Scientific Officer Named a PharmaVoice 100 Honoree
From Altasciences
Via Business Wire
Altasciences Receives 2024 CRO Leadership Award for Capabilities
From Altasciences
Via Business Wire
Altasciences Appoints New General Manager, Clinical Operations
From Altasciences
Via Business Wire
Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri
From Altasciences
Via Business Wire
Angel Reyes Joins Altasciences as General Manager of CDMO Services
From Altasciences
Via Business Wire
Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses
From Altasciences
Via Business Wire
Tickers VRPX
Altasciences Completes Successful Phase I Trial of Ischemix’ Novel Compound for Treatment of Traumatic Brain Injury (TBI)
From Altasciences
Via Business Wire
Altasciences Receives 2023 CRO Leadership Award for Capabilities
From Altasciences
Via Business Wire
Altasciences Completes Clinical Portion of Alzamend Neuro’s Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer’s
From Altasciences
Via Business Wire
Altasciences Receives Accreditation From College of American Pathologists
From Altasciences
Via Business Wire
Altasciences Expands Laboratory Capabilities in Columbia
From Altasciences
Via Business Wire
Altasciences Expands Strategic Support for Early Drug Development in Europe and Adds Key Employees to Its Preclinical Team in North America
From Altasciences
Via Business Wire
Altasciences Continues Manufacturing Expansion in Philadelphia With Client‑Dedicated Building Project
From Altasciences
Via Business Wire
Altasciences Receives CRO Leadership Award in Five Categories
From Altasciences
Via Business Wire
Dr. Wendell P. Davis Joins Altasciences as Vice President, Pathology
From Altasciences
Via Business Wire
Altasciences Acquires Sinclair Research and Continues to Expand Preclinical Platform
From Altasciences
Via Business Wire
Altasciences Chosen by Respira Technologies, Inc. as Drug Product Manufacturing Partner for the World’s First Inhaled Nicotine Replacement Therapy (NRT)
From Altasciences
Via Business Wire
Altasciences Chosen by XORTX Therapeutics, Inc. to Conduct Pharmacokinetic Bridging Study XRX-OXY-101 in Support of Developing New Therapies for Progressive Kidney Disease and Acute Kidney Injury
From Altasciences
Via Business Wire
Altasciences Expands Ligand Binding Laboratory to Meet High Demand for Bioanalytical Solutions
From Altasciences
Via Business Wire
Altasciences Continues Building Expansion with Additional Location in Philadelphia
From Altasciences
Via Business Wire
Bruce Frank Joins Altasciences as Vice President, CDMO Operations
From Altasciences
Via Business Wire
Altasciences Initiates Phase I Study in Healthy Normal Subjects for ST-2427, a Non-Opioid Analgesic for Acute Pain
From Altasciences
Via Business Wire
Altasciences Acquires Calvert Laboratories
From Altasciences
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.